Pradeep Bhadauria
Technik-/Wissenschafts-/F&E-Leiter bei CIPLA LIMITED
Aktive Positionen von Pradeep Bhadauria
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CIPLA LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | - |
Präsident | 01.01.2020 | - |
Karriereverlauf von Pradeep Bhadauria
Ehemalige bekannte Positionen von Pradeep Bhadauria
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 02.04.2019 | - |
Ausbildung von Pradeep Bhadauria
Shri Govindram Seksaria Institute of Technology & Science | Undergraduate Degree |
Birla Institute of Technology & Science | Graduate Degree |
Statistik
International
Indien | 4 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
President | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CIPLA LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Börse
- Insiders
- Pradeep Bhadauria
- Erfahrung